ASP8062 Phase 1 Study - A Placebo-controlled, Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Male and Female Subjects -
Phase of Trial: Phase I
Latest Information Update: 04 Oct 2018
Price : $35 *
At a glance
- Drugs ASP 8062 (Primary)
- Indications Fibromyalgia
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 31 Oct 2017 Status changed from active, no longer recruiting to completed.
- 09 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 05 Jul 2017 Status changed from not yet recruiting to recruiting.